scholarly article | Q13442814 |
P356 | DOI | 10.3109/08977199109104817 |
P953 | full work available at URL | http://www.tandfonline.com/doi/pdf/10.3109/08977199109104817 |
P698 | PubMed publication ID | 1768435 |
P50 | author | Goran Hansson | Q98467791 |
P2093 | author name string | J. Thyberg | |
P2860 | cites work | Biochimica et Biophysica Acta | Q864239 |
Pharmacological Reviews | Q2085079 | ||
Replication of smooth muscle cells in vascular disease | Q39731571 | ||
The effects of cyclosporin A on the immune system | Q39849792 | ||
Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells | Q41553699 | ||
Chloroquine and monensin inhibit induction of DNA synthesis in rat arterial smooth muscle cells stimulated with platelet-derived growth factor | Q41912012 | ||
Cyclosporin A inhibits phorbol ester-induced activation of superoxide production in resident mouse peritoneal macrophages | Q41975442 | ||
Potential mechanism of cyclosporine A-induced vascular smooth muscle contraction | Q42492734 | ||
Similar action of platelet-derived growth factor and epidermal growth factor in the prereplicative phase of human fibroblasts suggests a common intracellular pathway. | Q51221704 | ||
Expression of PDGF alpha- and beta-receptors in rat arterial smooth muscle cells is phenotype and growth state dependent. | Q53761338 | ||
Developmentally regulated production of platelet-derived growth factor-like molecules | Q59066829 | ||
Changes in expression and organization of smooth-muscle-specific alpha-actin during fibronectin-mediated modulation of arterial smooth muscle cell phenotype | Q67678990 | ||
Identification of growth-factor-inducible genes in mouse fibroblasts | Q68085010 | ||
Effect of cyclosporine, cyclosporine metabolite 17, and other cyclosporine-related compounds on T lymphocyte clones derived from rejected human kidney grafts. I. Inhibition of proliferation | Q68216028 | ||
Cyclosporin a suppresses proliferation of renal mesangial cells in culture | Q68307943 | ||
Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human Atheroma | Q68352602 | ||
Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to synthetic phenotype | Q69057873 | ||
A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype | Q69304699 | ||
Integrin-type fibronectin receptors of rat arterial smooth muscle cells: isolation, partial characterization and role in cytoskeletal organization and control of differentiated properties | Q69311619 | ||
Expression of three recombinant homodimeric isoforms of PDGF in Saccharomyces cerevisiae: evidence for difference in receptor binding and functional activities | Q69365010 | ||
Immune mechanisms in atherosclerosis | Q69539709 | ||
Dual effects of cyclosporine A on arachidonate metabolism by peritoneal macrophages. Phospholipase activation and partial thromboxane-synthase blockage | Q69647419 | ||
Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque | Q69990504 | ||
Fibronectin: purification, immunochemical properties, and biological activities | Q70353171 | ||
Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor | Q71241003 | ||
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin | Q24338951 | ||
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains | Q27860528 | ||
Signal transduction by the platelet-derived growth factor receptor | Q28251437 | ||
Platelet-derived growth factor: three isoforms and two receptor types | Q28252309 | ||
G1 events and regulation of cell proliferation | Q29618317 | ||
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins | Q29618460 | ||
Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury | Q33564406 | ||
Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall | Q33567932 | ||
The smooth muscle cell in culture | Q33951416 | ||
Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis | Q34541589 | ||
Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization | Q34563319 | ||
Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens | Q36204340 | ||
Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells | Q36221997 | ||
Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells | Q36356932 | ||
Regulation of differentiated properties and proliferation of arterial smooth muscle cells. | Q37997031 | ||
Mitogens and ion fluxes | Q38188980 | ||
The heparin-binding (fibroblast) growth factor family of proteins | Q38286731 | ||
Signal transmission by the insulin-like growth factors | Q38297337 | ||
Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation | Q38342696 | ||
Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. | Q38629840 | ||
The biology of platelet-derived growth factor | Q39502750 | ||
T-lymphocyte activation: the role of protein kinase C and the bifurcating inositol phospholipid signal transduction pathway | Q39508598 | ||
Molecular analysis of signal transduction by growth factors | Q39650738 | ||
The epidermal growth factor receptor as a multifunctional allosteric protein | Q39650742 | ||
Polypeptide growth factors: roles in normal and abnormal cell growth | Q39683843 | ||
The pathogenesis of atherosclerosis--an update | Q39726917 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell biology | Q7141 |
endocrinology | Q162606 | ||
cyclosporine | Q367700 | ||
P304 | page(s) | 209-219 | |
P577 | publication date | 1991-01-01 | |
P1433 | published in | Growth Factors Journal | Q5611728 |
P1476 | title | Cyclosporine A Inhibits Induction of DNA Synthesis by PDGF and Other Peptide Mitogens in Cultured Rat Aortic Smooth Muscle Cells and Dermal Fibroblasts | |
P478 | volume | 4 |
Q35833075 | Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. |
Q35063770 | Atherosclerotic plaque formation and risk factors |
Q37220939 | Calcineurin regulates cyclin D1 accumulation in growth-stimulated fibroblasts |
Q39429861 | Cellular hyperplasia in rats following continuous intravenous infusion of recombinant human epidermal growth factor |
Q45193067 | Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. |
Q41141172 | Differentiated properties and proliferation of arterial smooth muscle cells in culture. |
Q41581409 | Direct and endothelial cell-mediated effect of cyclosporin A on the proliferation of rat smooth muscle cells in vitro |
Q35795075 | How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. |
Q33890414 | Immunomodulation of atherosclerosis: myth and reality. |
Q41214653 | In vivo pharmacological effects of ciclosporin and some analogues |
Q73634952 | Strategies to antagonise the cyclosporine A-induced proliferation of human pulmonary artery smooth muscle cells: anti-endothelin-1 antibodies, verapamil, and octreotide |
Q37629703 | T lymphocytes inhibit the vascular response to injury |